3 Recruiting Multiple Myeloma Clinical Trials in Connecticut
Explore active multiple myeloma research studies enrolling across Connecticut. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Multiple Myeloma Studies in Connecticut
🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
📍 Yale New Haven Hospital — New Haven, Connecticut
View Study & Checklist ➔ 🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research
A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders
📍 Hartford Healthcare Alliance — Hartford, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔